| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |